Axon Enterprise, Inc $AXON Stock Position Increased by Farther Finance Advisors LLC

Key Points

• Farther Finance Advisors LLC increased its stake in Axon Enterprise by 1,299.2% during Q2, now holding shares valued at $5.6 million.
• Analysts have set new price targets for Axon Enterprise, with Morgan Stanley at $885.00 and Needham & Company at $870.00, reflecting strong confidence in the company's stock.
• Insiders sold a total of 44,932 shares over the last three months, with CEO Patrick W. Smith selling 10,000 shares for approximately $7.4 million.

Farther Finance Advisors LLC boosted its holdings in shares of Axon Enterprise, Inc (NASDAQ:AXON - Free Report) by 1,299.2% during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 6,758 shares of the biotechnology company's stock after buying an additional 6,275 shares during the period. Farther Finance Advisors LLC's holdings in Axon Enterprise were worth $5,596,000 as of its most recent SEC filing.

A number of other large investors have also added to or reduced their stakes in AXON. Brighton Jones LLC purchased a new stake in shares of Axon Enterprise during the 4th quarter valued at about $480,000. Woodline Partners LP bought a new stake in Axon Enterprise in the fourth quarter worth $2,929,000. Waverly Advisors LLC purchased a new stake in Axon Enterprise in the fourth quarter worth $596,000. Fourth Dimension Wealth LLC bought a new stake in Axon Enterprise during the fourth quarter valued at about $30,000. Finally, GF Fund Management CO. LTD. acquired a new stake in Axon Enterprise in the fourth quarter worth about $4,656,000. Hedge funds and other institutional investors own 79.08% of the company's stock.

Analyst Upgrades and Downgrades

Several brokerages have recently commented on AXON. Wolfe Research initiated coverage on Axon Enterprise in a research note on Monday, July 7th. They issued an "outperform" rating on the stock. Craig Hallum upgraded Axon Enterprise from a "hold" rating to a "buy" rating and set a $900.00 target price on the stock in a report on Tuesday, August 5th. JMP Securities upped their price objective on Axon Enterprise from $725.00 to $825.00 and gave the company a "market outperform" rating in a research note on Tuesday, July 22nd. Needham & Company LLC set a $870.00 price target on Axon Enterprise and gave the company a "buy" rating in a research note on Tuesday, August 5th. Finally, Zacks Research lowered Axon Enterprise from a "strong-buy" rating to a "hold" rating in a report on Tuesday, September 2nd. Thirteen equities research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. According to MarketBeat.com, the company has a consensus rating of "Moderate Buy" and an average price target of $837.69.

Axon Enterprise Stock Performance

Shares of NASDAQ:AXON traded up $8.06 on Friday, reaching $774.53. 1,738,952 shares of the company's stock were exchanged, compared to its average volume of 491,303. The company has a market capitalization of $60.80 billion, a price-to-earnings ratio of 191.24, a PEG ratio of 28.43 and a beta of 1.40. The company has a current ratio of 2.95, a quick ratio of 2.71 and a debt-to-equity ratio of 0.63. The company has a fifty day moving average of $759.97 and a 200-day moving average of $696.68. Axon Enterprise, Inc has a twelve month low of $387.06 and a twelve month high of $885.91.

Axon Enterprise (NASDAQ:AXON - Get Free Report) last issued its quarterly earnings data on Monday, August 4th. The biotechnology company reported $2.12 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.54 by $0.58. Axon Enterprise had a net margin of 13.64% and a return on equity of 6.80%. The firm had revenue of $668.54 million during the quarter, compared to analysts' expectations of $641.77 million. During the same period last year, the company earned $1.20 earnings per share. The business's revenue was up 32.6% on a year-over-year basis. Axon Enterprise has set its FY 2025 guidance at EPS. On average, research analysts predict that Axon Enterprise, Inc will post 5.8 EPS for the current fiscal year.

Insider Buying and Selling at Axon Enterprise

In related news, CEO Patrick W. Smith sold 10,000 shares of the business's stock in a transaction on Monday, August 11th. The shares were sold at an average price of $831.29, for a total value of $8,312,900.00. Following the sale, the chief executive officer owned 3,053,982 shares in the company, valued at approximately $2,538,744,696.78. The trade was a 0.33% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, President Joshua Isner sold 15,919 shares of the company's stock in a transaction dated Friday, August 15th. The shares were sold at an average price of $746.26, for a total transaction of $11,879,712.94. Following the transaction, the president owned 238,379 shares in the company, valued at approximately $177,892,712.54. This trade represents a 6.26% decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders have sold 44,932 shares of company stock valued at $34,408,816. 4.40% of the stock is currently owned by company insiders.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.